Lasa Supergenerics Ltd
₹4.44
-0.23 (4.93%)
Fri, 06 Nov 2026, 07:48 pm
Lasa Supergenerics News
Lasa Supergenerics approves Janardan Savala as Executive Director
Lasa Supergenerics board approved re-appointment of Dr. Omkar Herlekar and new Executive Director Janardan Savala. AGM set for September 30, 2026.
09 Sept 2026
companies
Lasa Supergenerics promoter discloses FY26 status
Omkar Herlekar reported no new share encumbrances in FY26. The disclosure was made under SEBI (SAST) Regulations.
02 Jun 2026
companies
LASA Supergenerics Q4FY26 related party transactions
LASA Supergenerics disclosed related party transactions for Q4FY26, including remuneration and donations totaling ₹35.36 lakh.
30 May 2026
companies
Lasa Supergenerics reports Q4FY26 net loss
Lasa Supergenerics reported a net loss of ₹416.44 lakh for Q4FY26. Revenue from operations stood at (₹13.15) lakh.
29 May 2026
companies
Lasa Supergenerics Board Meet Set for May 29, 2026
Lasa Supergenerics schedules board meeting on May 29, 2026 to approve audited financial results for Q4 and full year ended March 31, 2026.
19 May 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo